Literature DB >> 22260461

Distribution of aldehyde dehydrogenase 1-positive stem cells in benign mammary tissue from women with and without breast cancer.

Björn L Isfoss1, Bo Holmqvist, Per Alm, Håkan Olsson.   

Abstract

AIMS: Aldehyde dehydrogenase 1 (ALDH1) in female breast tissue has been linked to stem cells, but little is known about the benign cellular organization in situ. We investigated the distribution of ALDH1-immunoreactive (ALDH1+) cells in histomorphologically benign breast tissue from 28 women with or without breast cancer. METHODS AND
RESULTS: ALDH1+ cells were detected in benign tissue of women aged 20-72 years, located most commonly at the luminal and intermediate ductular levels and in the stroma. ALDH1+ cell populations and Ki67+ cell populations were present in separate ductules, both cell types rarely showing epithelial differentiation. ALDH1+ cells were non-reactive to Ki67 and oestrogen receptor. Stromal round/oval ALDH1+ non-leukocyte cells in both age groups expressed contractile protein. There was a lower concentration of luminal and intermediate ductular ALDH1+ cells in postmenopausal women than in premenopausal women, and in cancer patients than in non-cancer patients, and a higher concentration in women receiving exogenous hormones.
CONCLUSIONS: This study provides further evidence for the stem cell character of ALDH1+ cells, here in benign breast tissue of cancer and non-cancer patients throughout non-lactating adult life, and contributes evidence of benign stromal ALDH1+ cells. The distribution of ductular ALDH1+ stem cells appears to be influenced by hormonal status.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22260461     DOI: 10.1111/j.1365-2559.2011.04109.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  7 in total

1.  Aldehyde dehydrogenase 1 expression correlates with the invasion of breast cancer.

Authors:  Hong Pan; Naping Wu; Yaoyu Huang; Qin Li; Chenghao Liu; Mengdi Liang; Wenbin Zhou; Xiaoan Liu; Shui Wang
Journal:  Diagn Pathol       Date:  2015-06-13       Impact factor: 2.644

2.  Stellate cells and mesenchymal stem cells in benign mammary stroma are associated with risk factors for breast cancer - an observational study.

Authors:  Björn Logi Isfoss; Bo Holmqvist; Elin Sand; Johan Forsell; Helena Jernström; Håkan Olsson
Journal:  BMC Cancer       Date:  2018-02-27       Impact factor: 4.430

3.  Aldehyde dehydrogenase 1 expression in basal cell carcinoma, actinic keratosis and Bowen's disease.

Authors:  Mitsuaki Ishida; Hidetoshi Okabe
Journal:  Mol Clin Oncol       Date:  2013-04-18

4.  Aldehyde dehydrogenase and estrogen receptor define a hierarchy of cellular differentiation in the normal human mammary epithelium.

Authors:  Gabriella Honeth; Sara Lombardi; Christophe Ginestier; Minhee Hur; Rebecca Marlow; Bharath Buchupalli; Ireneusz Shinomiya; Patrycja Gazinska; Silvia Bombelli; Vernie Ramalingam; Anand D Purushotham; Sarah E Pinder; Gabriela Dontu
Journal:  Breast Cancer Res       Date:  2014-05-27       Impact factor: 6.466

5.  Women with familial risk for breast cancer have an increased frequency of aldehyde dehydrogenase expressing cells in breast ductules.

Authors:  Björn L Isfoss; Bo Holmqvist; Helena Jernström; Per Alm; Håkan Olsson
Journal:  BMC Clin Pathol       Date:  2013-11-04

6.  The absence of aldehyde dehydrogenase 1 A1-positive cells in benign mammary stroma is associated with risk factors for breast cancer.

Authors:  Björn Logi Isfoss; Bo Holmqvist; Helena Jernström; Per Alm; Håkan Olsson
Journal:  Breast Cancer (Dove Med Press)       Date:  2016-05-27

7.  Stromal expression of ALDH1 in human breast carcinomas indicates reduced tumor progression.

Authors:  Natalia Bednarz-Knoll; Paulina Nastały; Anna Żaczek; MaÅ Gorzata Stoupiec; Sabine Riethdorf; Harriet Wikman; Volkmar Müller; Jarosław Skokowski; Jolanta Szade; Aleksandra Sejda; Marzena Wełnicka-Jaśkiewicz; Klaus Pantel
Journal:  Oncotarget       Date:  2015-09-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.